MMP-14 Antibodies as Novel Therapeutics for Metastatic Cancers
Novel synthetic antibody that limits tumor progression and metastasis
Published: 12th April 2022

Patents
- No patent applications have yet been filed and antibody sequences have not been disclosed
IP Status
- No patent
Seeking
- Development partner
- Commercial partner
- Licensing
- Seeking investment